Two novel mutations in the DNAH11 gene in primary ciliary dyskinesia (CILD7) with considerable variety in the clinical and beating cilia phenotype.
Combined diagnostics
Compound heterozygosity
DNAH11 gene
Mild disease
PCD
PICADAR
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
26 11 2020
26 11 2020
Historique:
received:
31
07
2020
accepted:
10
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
9
1
2021
Statut:
epublish
Résumé
Diagnosis of primary ciliary dyskinesia (PCD) still remains a challenge, especially with mutations in the Dynein Arm Heavy Chain 11 (DNAH11) gene. Classical diagnostic measures like Transmission Electron Microscopy (TEM) are not applicable for mutations in the DNAH11 gene since ultrastructural defects of the ciliary apparatus are absent. Novel mutations encoding for PCD appear all the time with considerable variation in the clinical picture, making it necessary to update data bases and guidelines for PCD diagnostics. In this study we examined two unrelated, Finnish families with symptoms of PCD applying the clinical scoring system: Primary ciliary dyskinesia Rule (PICADAR), high speed video microscopy analysis (HSVMA) for ciliary movement, a commercially available gene panel analysis and nasal Nitric Oxide (nNO) measurements if applicable. Two, likely pathogenic variants in the DNAH11 gene (c.2341G > A, p. (Glu781Lys) ja c.7645 + 5G > A) were detected. In the first family, compound heterozygous mutations led to disease manifestation in two of 4 children, which showed a similar phenotype of cilia beating pattern but marked differences in disease severity. In the second family, all three children were homozygotes for the c.2341G > A p.(Glu781Lys) mutation and showed a similar degree of disease severity. However, the phenotype of cilia beating pattern was different ranging from stiff, static cilia to a hyperkinetic movement in one of these children. In this study we describe two Finnish families with PCD, revealing two novel mutations in the DNAH11 gene which show considerable variety in the clinical and beating cilia phenotype. The results of this study show the clinician that PCD can be much milder than generally expected and diagnosis demands a combination of measures which are only successful in experienced hands. Chronic and repeatedly treated wet cough should raise suspicion of PCD, referring the patient for further diagnostics to a specialised PCD centre.
Sections du résumé
BACKGROUND
Diagnosis of primary ciliary dyskinesia (PCD) still remains a challenge, especially with mutations in the Dynein Arm Heavy Chain 11 (DNAH11) gene. Classical diagnostic measures like Transmission Electron Microscopy (TEM) are not applicable for mutations in the DNAH11 gene since ultrastructural defects of the ciliary apparatus are absent. Novel mutations encoding for PCD appear all the time with considerable variation in the clinical picture, making it necessary to update data bases and guidelines for PCD diagnostics.
METHODS
In this study we examined two unrelated, Finnish families with symptoms of PCD applying the clinical scoring system: Primary ciliary dyskinesia Rule (PICADAR), high speed video microscopy analysis (HSVMA) for ciliary movement, a commercially available gene panel analysis and nasal Nitric Oxide (nNO) measurements if applicable.
RESULTS
Two, likely pathogenic variants in the DNAH11 gene (c.2341G > A, p. (Glu781Lys) ja c.7645 + 5G > A) were detected. In the first family, compound heterozygous mutations led to disease manifestation in two of 4 children, which showed a similar phenotype of cilia beating pattern but marked differences in disease severity. In the second family, all three children were homozygotes for the c.2341G > A p.(Glu781Lys) mutation and showed a similar degree of disease severity. However, the phenotype of cilia beating pattern was different ranging from stiff, static cilia to a hyperkinetic movement in one of these children.
CONCLUSIONS
In this study we describe two Finnish families with PCD, revealing two novel mutations in the DNAH11 gene which show considerable variety in the clinical and beating cilia phenotype. The results of this study show the clinician that PCD can be much milder than generally expected and diagnosis demands a combination of measures which are only successful in experienced hands. Chronic and repeatedly treated wet cough should raise suspicion of PCD, referring the patient for further diagnostics to a specialised PCD centre.
Identifiants
pubmed: 33243178
doi: 10.1186/s12881-020-01171-2
pii: 10.1186/s12881-020-01171-2
pmc: PMC7690114
doi:
Substances chimiques
Axonemal Dyneins
EC 3.6.4.2
DNAH11 protein, human
EC 3.6.4.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
237Références
Paediatr Respir Rev. 2016 Mar;18:18-24
pubmed: 26476603
Arch Dis Child. 2010 Jan;95(1):51-2
pubmed: 19720631
Orphanet J Rare Dis. 2014 Jan 22;9:11
pubmed: 24450482
Cilia. 2015 Jan 22;4(1):2
pubmed: 25610612
Eur Respir J. 2016 Apr;47(4):1103-12
pubmed: 26917608
Hum Mutat. 2008 Feb;29(2):289-98
pubmed: 18022865
Thorax. 2012 May;67(5):433-41
pubmed: 22184204
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur Respir J. 2017 Jan 4;49(1):
pubmed: 27836958
Arch Dis Child. 2007 Dec;92(12):1136-40
pubmed: 17634184
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Eur Respir J. 2011 Mar;37(3):559-65
pubmed: 20525709
Hum Mutat. 2012 Mar;33(3):495-503
pubmed: 22102620
Am J Hum Genet. 2019 Jul 3;105(1):198-212
pubmed: 31178125
Lancet Respir Med. 2020 Feb;8(2):202-216
pubmed: 31624012
J Community Genet. 2017 Oct;8(4):319-326
pubmed: 28730583
Am J Respir Crit Care Med. 2004 Feb 15;169(4):459-67
pubmed: 14656747
Circulation. 2007 Jun 5;115(22):2814-21
pubmed: 17515466